New Tools

  • Nenad Markovic
  • Olivera Markovic


MarkPap Illustrated is a summary of procedures and tools designed and developed to facilitate performing the mass cervical cancer screening under the auspices of the New Strategy.


Cervical Cancer Cervical Cancer Screening Vaginal Fluid Reporting Unit Center Processing Unit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 20.
    BioSciCon’s electronic Survey. Web Site link. Cited September 25, 2007
  2. 21.
    BioSciCon’s web portal:
  3. 22.
    BioSciCon’ MarkPap Self test.
  4. 84.
    Histopathology Atlas. Histopathology of the uterine cervix – digital atlas. Frappart L, Fontaniere B, Lucas E, Sankaranaranayan R. IARC Screening Group. ISBN 92 832 2424 8. Cited September 29, 2007
  5. 103.
    Kumar S. Nanolithography. In vivo optical detection of intracellular cancer biomarkers using gold nanoparticles. Spie Digital Library. Cited August 30, 2007
  6. 114.
    Markovic N, Markovic O (2000) CAP-PAP test. US Patent 6,143,512, 20 Nov 2000Google Scholar
  7. 115.
    Markovic O, Markovic N (2003/2004) Cervical acid phosphatase: a biomarker of cervical dysplasia and a potential surrogate endpoint for colposcopy. Dis Markers 19:279–286Google Scholar
  8. 116.
    Markovic N, Markovic O, Sundeen J (2004). BioSciCon Cervical Cancer Study Group. Pap test and a new biomarker-based technology for enhancing the visibility of abnormal cells. 2004 ASCO annual meeting, New Orleans, J Clin Oncol Suppl 22(1):9561. Slide presentation available on Cited September 19, 2007
  9. 117.
    Markovic N, Markovic O, Henderson E et al (2005) MarkPap test for cervical cancer screening. 2005 ASCO annual meeting. J Clin Oncol Suppl 23(1):1021 Slide presentation available on the Internet Cited September 25, 2007
  10. 118.
    Markovic N, Markovic O (2006) The power of the biomarker for cervical cancer control. 2006 ASCO annual meeting. J Clin Oncol Suppl 24:11001(18S). Cited July 7, 2007
  11. 119.
    Markovic N, Markovic O, Henderson E (2006) MarkPap digital, a new prospective for biomarker-based gynecological cytology. Ann meeting of the AACR, April 2006, Washington, DCGoogle Scholar
  12. 120.
    Markovic N, Markovic O (2007). MarkPap test and HPV vaccination. BIO international convention. 2006, innovative corridor, Boston…/Poster/Listing.aspx. www.bioscicon/publications.html. Cited August 1, 2007
  13. 121.
    Markovic O, Markovic N (2007) Will home Pap test be soon available. Experimental biology 2007 annual meeting, Washington, DC. The FASEB J 21(6):708.10Google Scholar
  14. 122.
    Markovic N, Markovic O (2003–2007). publications are available on the Internet at the BioSciCon web site
  15. 165.
    Tang YW, Stratton CW. Advanced techniques in Diagnostic Microbiology. Amazon. Cited September 4, 2007
  16. 194.
    Markovic O, Shulman NR (1977) Megakaryocyte maturation indicated by methanol inhibition of an acid phospahatase shared by megakariyocytes and platelets. Blood 50:905PubMedGoogle Scholar
  17. 195.
    Markovic N. BioSciCon presents the MarkPap technology. Larta-CAP Venture Forum 2007, San Francisco, May 2007.
  18. 196.
    Markovic N, Markovic O. Biomarker plus. 55th annual meeting of the American Society of Cytopathology, Nov 2007, Houston. Cancer cytopathology Suppl. 11/5,385,2007. Click here to download the abstract. (PDF format)
  19. 197.
    Markovic N, Markovic O. Ask for women’ s opinion first. Teaching and computer session. FASEB experimental biology, 2008. Today’s research: tomorrow’s health. San Diego California, April 5–9, 2008. Click here to download the abstract
  20. 198.
    Prabal D, Wenkateswaran Y, Bhatla N, Markovic O, Verma K (2008) Cervical acid Phosphatase detection: a guide to abnormal cells in cytology smear screening for cervical cancer. J Cytol 25(1):1–5. Click here to view the article
  21. 199.
    Iyer VK, Mathur SR, Bhatla N, Markovic O. Evaluation of cytology screening strategies for cervical cancer in resource poor settings. 18th International Congress of Cytology, Paris, May 2013. Click here to view the abstract
  22. 200.
    Neha B, Agrawal PM, Santwani M (2015) Staudy of CAPPAP versus conventional papa in suspicious cervical lesions. Int J Res Med 4(1):102–108Google Scholar
  23. 201.
    Niranjan J, Prakash CJ (2015) Cervical acid Phosphatase: evaluation as a an adjuvant to Papanicolaou smears screening in cervical cancer detection. J Evid Based Med Healthc 2(6):714–732Google Scholar
  24. 202.
    Markovic O, Markovic N. MarkPap technology: a prospective for global cervical cancer control. FASEB annual meeting, experimental biology 2006, San FranciscoGoogle Scholar
  25. 204.
    Anyon Biopharmaceuticals in Anhui, China. Assessed July 2016
  26. 205.
    Anhui Anke Biotechnology Group Co, Ltd ankebio@mail.hf/ Accessd July 2015Google Scholar
  27. 206.
    Markovic O, Markovic N (2007) Will home Pap test be soon available? Experimental biology 2007. The FASEB J 2007 21(6), A 754, 708.10. Click here to view the article
  28. 207.
    Markovic O, Markovic N (2012) Is mass cytological cancer screening possible worldwide? The FASEB J 26, 657.1. Click here to view the abstract
  29. 208.
    Markovic O, Markovic N. Meeting the recommendations for cervical cancer screening in developing counties. 2014 national conference on cancer detection, diagnosis and treatment for global health. NIH, Bethesda, January 2014. Click here to view
  30. 209.
    Markovic N, Markovic O (2008/2010) What every women should know about cervical cancer. Springer, Dordrecht.
  31. 210. Accessed June 2015
  32. 211.
  33. 212.
  34. 213.
    Markovic O, Markovic N (2013) IT telehealth center for telecytopathology. The FASEB J 27:874.20. Click here to view the abstract
  35. 214.
    Markovic N, Markovic O, Panashchenko O, McJonathan S. A tool for integration of cytology, HPV screening and telecytopathology. BIO 2008 international convention. San Diego, June 2008. Click here to download the abstract
  36. 215.
    Markovic O, Markovic N. IT enables same-day Pap test. Experimental Biology 2009, FASEB, April 2009. Click here to read the abstract
  37. 216.
    Markovic O, Markovic N. Cell phones as a new m-Health opportunity for mass cervical cancer screening. Experimental Biology 2010, FASEB, April 2010. Click here to read the abstract
  38. 217.
    BioSciCon’s most recent advances in wireless telecytopathology. Click here to view the document
  39. 218.
    Markovic O, Markovic N. Further studies on the application of wireless cytopathology for detection of cervical cancer and initial screening for oral cancer. FASEB national meeting, Experimental Biology 2011, Washington, DC, April 2011. Click here to download the abstract
  40. 219.
    Markovic O, Markovic N (2012) Universal adapter for telecytopathology. The FASEB J 26, 1b476. Click here to view the abstract
  41. 220. html. Accessed June 2015
  42. 221.
    MarkPap India, LLC. Fighting cervical cancer in India. Brochure that can be retrieved by clicking on the link.Ch9/1
  43. 222.
    MarkPap Pacific, LLC. Cervical cancer in China. Brochure. Annex. China_13_brochure, F_2.pdf.Ch.9/2Google Scholar
  44. 225.
    Personal communications 2006–2015Google Scholar
  45. 226.
    Markovic N, Markovic O, Sundeen J (2004) Cervical acid phosphatase and Preservecyt®. Inv Med 52(Supp 2):80. See also reference 220, #10Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2016

Authors and Affiliations

  • Nenad Markovic
    • 1
  • Olivera Markovic
    • 2
  1. 1.Global Academy for Women’s Health, Inc.Medical Center DriveRockvilleUSA
  2. 2.Education Global Academy for Women’s Health, Inc.RockvilleUSA

Personalised recommendations